Cyclacel Pharmaceuticals Story

Cyclacel Pharmaceuticals Inc -- USA Stock  

USD 1.39  0.04  2.80%

Macroaxis does not monitor all media channels or aggregates social signals for Cyclacel Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Cyclacel Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Cyclacel Pharmaceuticals. Check also Cyclacel Pharmaceuticals Hype Analysis, Cyclacel Pharmaceuticals Correlation and Cyclacel Pharmaceuticals Performance
The sentiment expressed by investors TimkenSteel Corporation , Cyclacel ...
Taking a close look at the activity of the stock of TimkenSteel Corporation , during the trading sessions, it is clear to see that the prices of their shares moved to 12.83.

Read More...   

Story Momentum

This media report from distributed on December 7, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 9.29% . The overall trading delta when the story was published against the current closing price is 21.31% .

Similar stores for Cyclacel Pharmaceuticals

Analyst Research Roundup KNOT Offshore Partners LP , Cyclacel Pharmaceuticals,
Analyst JournalFull coverage
over a month ago at 
ValuEngine Upgrades Cyclacel Pharmaceuticals to Sell
The Ledger GazetteFull coverage
over two months ago at 
There Is Something To Be Excited About Cyclacel Pharmaceuticals, Inc. CYCC ...
VRX mean recommendation on Reuter scale presents no change from 2.95 thirty days ago to 2.95 now, which indicates a hold consensus from the analyst community.

Did you try this?

Run Piotroski F Score Now

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Hide  View All  NextLaunch Piotroski F Score

Current Ratio

Current Ratio Comparative Analysis
  Current Ratio 
      Cyclacel Pharmaceuticals Comparables 
Cyclacel Pharmaceuticals is currently under evaluation in current ratio category among related companies. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.